Arcus Biosciences, Inc.
RCUS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001724521
In the last 90 days, Arcus Biosciences, Inc. insiders filed 0 open-market purchases and 2 sales; 231 institutions reported holding it in 13F filings for Q2 2026, worth $3.78B in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Arcus Biosciences, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 190
- +5 vs. Q2 2025
- Shares held
- 100.6M
- +903.6K (+0.9%) vs. Q2 2025
- Total value
- $1.37B
- +$556.8M (+68.6%) vs. Q2 2025
- New holders
- 29
- 66 more added
- Sold out
- 24
- 61 more reduced
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RCUS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 231 | $3.78B |
| Q1 2026 | 211 | $2.57B |
| Q4 2025 | 209 | $2.89B |
| Q3 2025 | 190 | $1.37B |
| Q2 2025 | 186 | $811.5M |
| Q1 2025 | 187 | $763.3M |
| Q4 2024 | 186 | $1.25B |
| Q3 2024 | 187 | $815.7M |
| Q2 2024 | 193 | $790.9M |
| Q1 2024 | 172 | $997.7M |
| Q4 2023 | 185 | $1.01B |
| Q3 2023 | 187 | $947.9M |
| Q2 2023 | 181 | $1.11B |
| Q1 2023 | 180 | $1.01B |
| Q4 2022 | 200 | $1.11B |
| Q3 2022 | 183 | $1.37B |
| Q2 2022 | 173 | $1.33B |
| Q1 2022 | 157 | $1.60B |
| Q4 2021 | 142 | $2.06B |
| Q3 2021 | 131 | $1.68B |
| Q2 2021 | 130 | $1.24B |
| Q1 2021 | 148 | $1.25B |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Arcus Biosciences, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| XTX Topco Ltd | 0 | $0 | 0.00% | −35,998−100.0% | Sold out |
| Maryland State Retirement & Pension System | 0 | $0 | 0.00% | −20,202−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −16,794−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −15,603−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −13,540−100.0% | Sold out |
| DRW Securities, LLC | 0 | $0 | 0.00% | −13,285−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −12,796−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −11,304−100.0% | Sold out |
| PEAK6 LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −7,991−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −417−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −362−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −242−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| E Fund Management Co., Ltd. | – | – | – | – | Not filed |